Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease

Archive ouverte

Laville, Pierre | Petitjean, Michel | Regad, Leslie

Edité par CCSD ; MDPI -

Supplemental information: https://figshare.com/articles/dataset/Data_of_Laville_et_al_2021/13634147. International audience. The use of antiretroviral drugs is accompanied by the emergence of HIV-2 resistances. Thus, it is important to elucidate the mechanisms of resistance to antiretroviral drugs. Here, we propose a structural analysis of 31 drug-resistant mutants of HIV-2 protease (PR2) that is an important target against HIV-2 infection. First, we modeled the structures of each mutant. We then located structural shifts putatively induced by mutations. Finally, we compared wild-type and mutant inhibitor-binding pockets and interfaces to explore the impacts of these induced structural deformations on these two regions. Our results showed that one mutation could induce large structural rearrangements in side-chain and backbone atoms of mutated residue, in its vicinity or further. Structural deformations observed in side-chain atoms are frequent and of greater magnitude, that confirms that to fight drug resistance, interactions with backbone atoms should be favored. We showed that these observed structural deformations modify the conformation, volume, and hydrophobicity of the binding pocket and the composition and size of the PR2 interface. These results suggest that resistance mutations could alter ligand binding by modifying pocket properties and PR2 stability by impacting its interface. Our results reinforce the understanding of the effects of mutations that occurred in PR2 and the different mechanisms of PR2 resistance.

Suggestions

Du même auteur

A non-parametric method to compute protein–protein and protein–ligands interfaces. Application to HIV-2 protease–inhibitors complexes

Archive ouverte | Laville, Pierre | CCSD

biorXiv paper ; DOI 10.1101/498923 ; https://doi.org/10.1101/498923 ;https://www.biorxiv.org/content/10.1101/498923v1. Motivation The accurate description of interfaces is needed to identify which residues interact ...

Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease

Archive ouverte | Laville, Pierre | CCSD

International audience. Background: Drug resistance is a severe problem in HIV treatment. HIV protease is a common target for the design of new drugs for treating HIV infection. Previous studies have shown that the ...

Exploration of the Structural Asymmetry Induced by the Intrinsic Flexibility of HIV-2 Protease

Archive ouverte | Badel, Anne | CCSD

International audience. HIV-2 protease (PR2) is a homodimer targeted by drugs in the treatment of HIV-2 infections. This dimer is often considered symmetric. However, exploration of crystallographic structures showe...

Chargement des enrichissements...